Interferon alfa: hyperpigmentation
Prescrire international 23(154): 268
2014
ISSN/ISBN: 1167-7422 PMID: 25954797 Document Number: 676782
Document emailed within 1 workday
Related Documents
Fernández, I.; Castellano, G.; Canga, F.; Colina, F.; García, H.; Fuertes, A.; Casis, B.; Martín, A.; Solís, J.A. 1995: A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C Gastroenterologia y Hepatologia 18(2): 66-72Nevens, F.; Van Vlierberghe, H.; D'Heygere, E.; Delwaide, J.; Adler, M.; Henrion, J.; Lenaerts, A.; Hendlisz, A.; Michielsen, P.; Bastens, B.; Brenard, R.; Laureys, A. 2010: A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients Acta Gastro-Enterologica Belgica 73(2): 223-228
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Haase-Statz, S.; Smalley, R.V. 1999: Role of interferon-alfa in NHL: still controversial? Oncology 13(8): 1147-1159; Discussion: 1159-1160, 1163
2001: Treatment of chronic hepatitis B: interferon alfa first Prescrire International 10(51): 17-21
Adam, Z. 1993: Interferon-alfa in the treatment of myeloproliferative diseases Vnitrni Lekarstvi 39(12): 1210-1218
Neuwirtová, R.; Cermák, J.; Kvasnicka, J.; Sedlácková, M. 1989: Treatment of hairy-cell leukemia using interferon alfa Casopis Lekaru Ceskych 128(34): 1065-1070
Cianciara, J.; Laskus, T.; Hryniewicz, H.; Jabłońska, J.; Loch, T. 1991: Treatment of chronic hepatitis B with interferon alfa-2b (Intron A) Przeglad Epidemiologiczny 45(4): 315-320
Machiulaĭtene, E.R.; Lasunskaia, E.B.; Nefedova, I.B.; Perekalina, T.A.; Salogub, G.N.; Poliakova, L.E. 1996: The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia Terapevticheskii Arkhiv 68(10): 44-47
Espinassouze, F.; Heid, E.; Grosshans, E. 1993: Treatment of keloid by intralesional injections of interferon alfa-2B Annales de Dermatologie et de Venereologie 120(9): 629-630
Morra, E.; Alimena, G.; Lazzarino, M.; Liberati, A.M.; Montefusco, E.; Bernasconi, P.; Mancini, M.; Donti, E.; Merante, S.; Caricchi, P. 1993: Evolving approaches with interferon alfa in chronic myelogenous leukemia Seminars in Hematology 30(3 Suppl 3: 26-27
Moyano Calvo, J.L.; Teba del Pino, F.; Sanz Sacristán, J.; Fernández Arjona, M.; Arellano Gañan, R.; Rabadán Ruiz, M.; Herrero Torres, L.; Melón Rey, F.J.; Pereira Sanz, I. 1995: Immunoprophylaxis of superficial tumors of the bladder with interferon alfa-2b. our experience Archivos Espanoles de Urologia 48(1): 55-59
Zouboulis, C.C.; Orfanos, C.E. 1998: Treatment of Adamantiades-Behçet disease with systemic interferon alfa Archives of Dermatology 134(8): 1010-1016
Gómez-Almaguer, D.; Jaime-Pérez, J.C.; Herrera-Garza, J.L.; González-Llano, O. 1998: Intermittent interferon alfa in the treatment of hairy cell leukemia Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 50(4): 331-334
Kuzel, T.M.; Gilyon, K.; Springer, E.; Variakojis, D.; Kaul, K.; Bunn, P.A.; Evans, L.; Roenigk, H.H.; Rosen, S.T. 1990: Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma Journal of the National Cancer Institute 82(3): 203-207
Sood, A.; Midha, V.; Sood, N.; Bansal, M. 2006: Pegylated interferon alfa 2b and oral ribavirin in patients with HCV-related cirrhosis Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(6): 283-285
Nightingale, S.L. 1989: From the Food and Drug Administration. Interferon alfa approved for Kaposi's sarcoma JAMA 261(3): 350
Liu, Y.-s.; Zhang, W.-d.; Yang, C.-h.; Sun, Y.-f.; Geng, B. 2006: Effect of interferon alfa therapy on malignant melanoma of oral mucosa Shanghai Kou Qiang Yi Xue 15(3): 263-268
Bernhard, H.; Klein, O.; Meyer zum Büschenfelde, K.H.; Knuth, A. 1992: Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a Seminars in Oncology 19(2 Suppl 3: 204-207
Tulli, A.; Biele, M.M.; Capizzi, R. 1988: A possible visceralization in a case of cutaneous T cell lymphoma under treatment with recombinant interferon alfa 2 Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 123(5): 262